Innovation Fund Denmark grants DKK 11 million for new diagnostic test

With the grant, Professor Winnie Svendsen, DTU Bioengineering, will develop a diagnostic test that can give doctors a quick answer to whether patients in shock can tolerate adrenaline in acute treatment. The test will be used in a pilot study with 200 patients with septic shock who will receive either beta-blockers or a placebo.

The COMBAT-TOX (Combat TOXic Catecholamine Syndrome Induced Mortality) study is carried out in collaboration with the intensive care units at Herlev, Bispebjerg and Nordsjælland hospitals.

Read more about the grant at the Innovation Fund Denmark. (In Danish)